e-learning
resources
Madrid 2019
Monday, 30.09.2019
Real-world experience of monoclonal antibodies in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of the steroid sparing effects of Mepolizumab using the Glucocorticoid Toxicity Index
P. McDowell (Belfast, United Kingdom), J. Stone (Boston, United States of America), K. Honeyford (Belfast, United Kingdom), L. Dunn (Belfast, United Kingdom), R. Logan (Belfast, United Kingdom), C. Butler (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom)
Source:
International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Session:
Real-world experience of monoclonal antibodies in asthma
Session type:
Thematic Poster
Number:
2513
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. McDowell (Belfast, United Kingdom), J. Stone (Boston, United States of America), K. Honeyford (Belfast, United Kingdom), L. Dunn (Belfast, United Kingdom), R. Logan (Belfast, United Kingdom), C. Butler (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom). Evaluation of the steroid sparing effects of Mepolizumab using the Glucocorticoid Toxicity Index. 2513
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
Source: Eur Respir J, 59 (1) 2100160; 10.1183/13993003.00160-2021
Year: 2022
The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018
Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Simulating the Beneficial Effects of Aerobic Exercise in Asthma in vitro: a way to Understand the Cellular Effects of Exercise in Asthma – Involvement of STAT6
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis
Source: International Congress 2018 – COPD management
Year: 2018
Curcumin as an Add-on Therapy of Moderate Partially Controlled Asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Nicotine Replacement Therapy
Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies
Year: 2005
Predicting Recurrent Oral Corticosteroid Use in the WATCH cohort
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Effects of Regular Use of ß2-Adrenergic Receptor Agonists on the Risk of Parkinson’s Disease in Patients with COPD
Source: International Congress 2019 – More and more COPD
Year: 2019
Comparing Lung Geometrical Areas of interest in Gamma Scintigraphy as Assessment Tool for Inhaled Drug Deposition
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Late Breaking Abstract - Long-term Effect of Antithrombin or Argatroban for the Treatment of Acute Lung Injury
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease.
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept